An evaluation of podiatry service use for people with inflammatory rheumatic diseases: a review of a rheumatology podiatry clinic in Aotearoa New Zealand.


Journal

Journal of foot and ankle research
ISSN: 1757-1146
Titre abrégé: J Foot Ankle Res
Pays: England
ID NLM: 101471610

Informations de publication

Date de publication:
16 May 2022
Historique:
received: 14 03 2022
accepted: 29 04 2022
entrez: 16 5 2022
pubmed: 17 5 2022
medline: 19 5 2022
Statut: epublish

Résumé

Foot problems, including foot pain, structural deformities, skin and nail lesions, and footwear difficulties, are common in people with inflammatory rheumatic diseases. However, dedicated podiatry services are limited, including in Aotearoa New Zealand. This study aimed to evaluate the podiatry service use for people with inflammatory rheumatic diseases who attended a specialist podiatric rheumatology clinic in Aotearoa New Zealand. This retrospective review included people with an inflammatory rheumatic disease who attended the Auckland University of Technology Podiatric Rheumatology Clinic between 2010 and 2021. Data were extracted manually from patients' clinical records, including variables relating to patient characteristics, appointment details, presenting complaint, assessments performed, and treatments provided. From 2010 to 2021, 157 people with inflammatory rheumatic diseases attended 1570 appointments. The most common presenting concern was foot pain (reported by n = 121, 77.1% patients during at least one appointment), followed by skin/nail lesions (n = 98, 62.4%) and footwear/orthotic needs (n = 90, 57.3%). A range of podiatric interventions were provided to address foot-care needs, in which education (n = 151, 96.2%) and general skin/nail care (n = 107, 68.2%) were the most common treatments provided. The majority of patients also received footwear interventions at some point during their period of service provision (n = 96, 61.1%), followed by orthoses, other padding/offloading devices, wound care, exercise prescription and referrals to other health professionals. This is the first study to review podiatric service provision for people with inflammatory rheumatic diseases attending a specialist podiatric rheumatology clinic in Aotearoa New Zealand. The results of this study have shown that a podiatry clinic dedicated to people with inflammatory rheumatic diseases addresses the wide range of foot problems through an extensive provision of treatment services.

Sections du résumé

BACKGROUND BACKGROUND
Foot problems, including foot pain, structural deformities, skin and nail lesions, and footwear difficulties, are common in people with inflammatory rheumatic diseases. However, dedicated podiatry services are limited, including in Aotearoa New Zealand. This study aimed to evaluate the podiatry service use for people with inflammatory rheumatic diseases who attended a specialist podiatric rheumatology clinic in Aotearoa New Zealand.
METHODS METHODS
This retrospective review included people with an inflammatory rheumatic disease who attended the Auckland University of Technology Podiatric Rheumatology Clinic between 2010 and 2021. Data were extracted manually from patients' clinical records, including variables relating to patient characteristics, appointment details, presenting complaint, assessments performed, and treatments provided.
RESULTS RESULTS
From 2010 to 2021, 157 people with inflammatory rheumatic diseases attended 1570 appointments. The most common presenting concern was foot pain (reported by n = 121, 77.1% patients during at least one appointment), followed by skin/nail lesions (n = 98, 62.4%) and footwear/orthotic needs (n = 90, 57.3%). A range of podiatric interventions were provided to address foot-care needs, in which education (n = 151, 96.2%) and general skin/nail care (n = 107, 68.2%) were the most common treatments provided. The majority of patients also received footwear interventions at some point during their period of service provision (n = 96, 61.1%), followed by orthoses, other padding/offloading devices, wound care, exercise prescription and referrals to other health professionals.
CONCLUSIONS CONCLUSIONS
This is the first study to review podiatric service provision for people with inflammatory rheumatic diseases attending a specialist podiatric rheumatology clinic in Aotearoa New Zealand. The results of this study have shown that a podiatry clinic dedicated to people with inflammatory rheumatic diseases addresses the wide range of foot problems through an extensive provision of treatment services.

Identifiants

pubmed: 35578311
doi: 10.1186/s13047-022-00542-7
pii: 10.1186/s13047-022-00542-7
pmc: PMC9108704
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

36

Subventions

Organisme : Arthritis New Zealand
ID : SS68

Informations de copyright

© 2022. The Author(s).

Références

Int J Equity Health. 2019 Oct 28;18(1):163
pubmed: 31660988
Ann Rheum Dis. 2010 May;69(5):928
pubmed: 20413569
J Foot Ankle Res. 2016 Apr 26;9:13
pubmed: 27118995
Arthritis Care Res (Hoboken). 2020 Jan;72(1):122-130
pubmed: 30629828
J Foot Ankle Res. 2018 Nov 26;11:64
pubmed: 30505351
J Foot Ankle Res. 2012 Jan 10;5(1):2
pubmed: 22233879
J Foot Ankle Res. 2021 Feb 25;14(1):15
pubmed: 33632287
Gait Posture. 2016 Feb;44:18-22
pubmed: 27004627
Baillieres Best Pract Res Clin Rheumatol. 2000 Sep;14(3):425-44
pubmed: 10985979
Foot (Edinb). 2017 Jun;31:6-12
pubmed: 28282539
J Foot Ankle Res. 2017 Oct 27;10:46
pubmed: 29090022
Musculoskeletal Care. 2013 Dec;11(4):218-28
pubmed: 23348757
Expert Rev Clin Immunol. 2018 Jan;14(1):21-28
pubmed: 29202587
Clin Rheumatol. 2007 Dec;26(12):2043-2050
pubmed: 17404783
Rheumatology (Oxford). 2009 Apr;48(4):436-9
pubmed: 19174570
J Foot Ankle Res. 2015 Aug 18;8:41
pubmed: 26288657
J Foot Ankle Res. 2009 May 15;2:16
pubmed: 19442310
J Foot Ankle Res. 2018 Jun 05;11:27
pubmed: 29928316
J Foot Ankle Res. 2016 Jan 06;9:1
pubmed: 26740821
Joint Bone Spine. 2009 Dec;76(6):648-53
pubmed: 19775924
Rheumatology (Oxford). 2001 Apr;40(4):410-3
pubmed: 11312379
Musculoskeletal Care. 2011 Jun;9(2):86-92
pubmed: 21259413
J Foot Ankle Res. 2017 Jan 25;10:4
pubmed: 28138340
Int J Equity Health. 2011 Oct 20;10:45
pubmed: 22014211
J Foot Ankle Res. 2013 Aug 13;6(1):34
pubmed: 23938103
Clin Rehabil. 2012 Oct;26(10):952-9
pubmed: 22275462
J Foot Ankle Res. 2016 Aug 17;9:29
pubmed: 27540415
Rheumatology (Oxford). 2006 Sep;45(9):1167-9
pubmed: 16844700
J Foot Ankle Res. 2013 Aug 26;6(1):35
pubmed: 23972081

Auteurs

Vy Nguyen (V)

School of Clinical Sciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, 90 Akoranga Drive, Northcote, Auckland, New Zealand.

Angela Brenton-Rule (A)

School of Clinical Sciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, 90 Akoranga Drive, Northcote, Auckland, New Zealand.
Active Living and Rehabilitation: Aotearoa New Zealand, Health and Rehabilitation Research Institute, School of Clinical Sciences, Auckland University of Technology, Private Bag 92 006, Auckland, 1142, New Zealand.

Nicola Dalbeth (N)

Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand.

Keith Rome (K)

School of Clinical Sciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, 90 Akoranga Drive, Northcote, Auckland, New Zealand.

Sarah Stewart (S)

School of Clinical Sciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, 90 Akoranga Drive, Northcote, Auckland, New Zealand. sarah.stewart@aut.ac.nz.
Active Living and Rehabilitation: Aotearoa New Zealand, Health and Rehabilitation Research Institute, School of Clinical Sciences, Auckland University of Technology, Private Bag 92 006, Auckland, 1142, New Zealand. sarah.stewart@aut.ac.nz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH